Schedules of Controlled Substances: Placement of Ganaxolone in Schedule V
scheduling · Rule · Final rule. · Published 2022-11-09 · 87 FR 67548
Document
Document number
2022-24157
Federal Register citation
87 FR 67548
Type
Rule
Action
Final rule.
Category
scheduling
Publication date
2022-11-09
Abstract
This final rule adopts, without change, an interim final rule with request for comments published in the Federal Register on June 1, 2022, placing ganaxolone (3[alpha]-hydroxy-3[beta]-methyl-5[alpha]- pregnan-20-one) and its salts in schedule V of the Controlled Substances Act. With the issuance of this final rule, the Drug Enforcement Administration maintains ganaxolone, including its salts, in schedule V of the Controlled Substances Act.